Financials

  • Market Capitalization 2.06 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.3
Rapporto prezzo/fatturato
162.41

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1967
VCEL
Vericel Corporation - Common Stock
41.32 USD+0.34%-3.23%-11.31%+13.67%2.12 B USD
1969
ADMA
ADMA Biologics Inc - Common Stock
9.35 USD-1.37%-4.98%+7.35%-46.26%2.09 B USD
1990
STOK
Stoke Therapeutics, Inc. - Common Stock
31.82 USD-2.36%-1.73%+8.12%+59.10%2.05 B USD
1998
ZYME
Zymeworks Inc. - Common Stock
28.62 USD-1.34%+3.92%+26.30%+61.33%2.03 B USD